홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,4-Dihydroxy-2,2,6,6-tetramethylpiperidine → 2,4,8,10-Tetra-tert-butyl-6-[1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yloxy]-dibenzo[d,g][1,3,2]dioxaphosphocin

HRID 1383027
인쇄

반응식

HRID 1383027 반응식
[P:1](Cl)(Cl)Cl.[CH2:5]([C:21]1[CH:26]=[C:25]([C:27]([CH3:30])([CH3:29])[CH3:28])[CH:24]=[C:23]([C:31]([CH3:34])([CH3:33])[CH3:32])[C:22]=1[OH:35])[C:6]1[CH:11]=[C:10]([C:12]([CH3:15])([CH3:14])[CH3:13])[CH:9]=[C:8]([C:16]([CH3:19])([CH3:18])[CH3:17])[C:7]=1[OH:20].[OH:36][N:37]1[C:42]([CH3:44])([CH3:43])[CH2:41][CH:40]([OH:45])[CH2:39][C:38]1([CH3:47])[CH3:46]>C(N(CC)CC)C>[C:27]([C:25]1[CH:24]=[C:23]([C:31]([CH3:34])([CH3:33])[CH3:32])[C:22]2[O:35][P:1]([O:45][CH:40]3[CH2:41][C:42]([CH3:43])([CH3:44])[N:37]([OH:36])[C:38]([CH3:47])([CH3:46])[CH2:39]3)[O:20][C:7]3[C:8]([C:16]([CH3:19])([CH3:18])[CH3:17])=[CH:9][C:10]([C:12]([CH3:15])([CH3:13])[CH3:14])=[CH:11][C:6]=3[CH2:5][C:21]=2[CH:26]=1)([CH3:30])([CH3:29])[CH3:28]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 53951,4-Dihydroxy-2,2,6,6-tetramethylpiperidineHCID 24387Phosphorus trichlorideHCID 843912,2'-Methylenebis(4,6-di-tert-butylphenol)

생성물 1

HCID 703887822,4,8,10-Tetra-tert-butyl-6-[1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yloxy]-dibenzo[d,g][1,3,2]dioxaphosphocin

시약·촉매·용매 1

HCID 8471Triethylamine
용매

실험 절차

The above-named compound is prepared by the general procedure of Example 1 by reacting 8.8 ml of phosphorous trichloride, 42.54 grams of 2,2'-methylene bis-(4,6-di-tert-butylphenol), 36.8 ml of triethylamine and 11.03 grams of 1,4-dihydroxy-2,2,6,6-tetramethylpiperidine.

후처리

  1. customThe above-named compound is prepared by the general procedure of Example 1

출처 및 근거

ORD 기록
ord-c36ed012a8e6492e933ac9657f88d11d
출처 데이터셋
uspto-grants-1989_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04808645

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트